MKULQ — Molekule Cashflow Statement
0.000.00%
- $0.01m
 - $30.91m
 - $0.23m
 
Annual cashflow statement for Molekule, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st  | 2020 December 31st  | 2021 December 31st  | 2022 December 31st  | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | 
| Net Income/Starting Line | -0.153 | -3.32 | -7.92 | -6.17 | 
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0 | 0.062 | 1.19 | -6.2 | 
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.057 | 0.191 | -0.819 | 2.07 | 
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.096 | -3.07 | -7.8 | -10.6 | 
| Capital Expenditures | 0 | -0.455 | -1.75 | -0.157 | 
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | -0.35 | 
| Acquisition of Business | ||||
| Cash from Investing Activities | 0 | -0.455 | -1.75 | -0.507 | 
| Financing Cash Flow Items | — | — | -3.47 | -1.42 | 
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 5.86 | 26.8 | 13.6 | 
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.096 | 2.33 | 17.3 | 2.43 |